| Autor: |
Tamirou, F. D'Cruz, D. Sangle, S. Remy, P. Vasconcelos, C. Fiehn, C. Del Mar Ayala Guttierez, M. Gilboe, I.-M. Tektonidou, M. Blockmans, D. Ravelingien, I. Le Guern, V. Depresseux, G. Guillevin, L. Cervera, R. Houssiau, F.A. Abramowicz, D. Atzeni, F. Danieli, M.G. De Clercq, L. De Ramon Garrido, E. De Keyser, F. Delahousse, M. Espinosa, G. Golstein, M. Hirsch, M. Karras, A. Lang, P. Marchal, M. Marinho, A. Max, R. Peeters, P. Petera, P. Petrovic, R. Quémeneur, T. Raeman, F. Sarzi-Puttini, P. De Santis, L.V. Verresen, L. Weiss, L. Westhovens, R. MAINTAIN Nephritis Trial Group |
| Jazyk: |
angličtina |
| Rok vydání: |
2016 |
| Předmět: |
|
| Popis: |
Objective: To report the 10-year follow-up of the MAINTAIN Nephritis Trial comparing azathioprine (AZA) and mycophenolate mofetil (MMF) as maintenance therapy of proliferative lupus nephritis, and to test different definitions of early response as predictors of long-term renal outcome. Methods: In 2014, data on survival, kidney function, 24 h proteinuria, renal flares and other outcomes were collected for the 105 patients randomised between 2002 and 2006, except in 13 lost to follow-up. Results: Death (2 and 3 in the AZA and MMF groups, respectively) and end-stage renal disease (1 and 3, respectively) were rare events. Time to renal flare (22 and 19 flares in AZA and MMF groups, respectively) did not differ between AZA and MMF patients. Patients with good long-term renal outcome had a much more stringent early decrease of 24 h proteinuria compared with patients with poor outcome. The positive predictive value of a 24 h proteinuria |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
